Results 231 to 240 of about 17,175,483 (375)

Myocardial deformation imaging to monitor treatment response in AL amyloidosis: is it worth the strain? [PDF]

Eur Heart J Open
Castiglione V, Gentile F, Vergaro G.
europepmc   +1 more source

AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies

JACC CardioOncology, 2021
G. Bianchi, Yifei Zhang, R. Comenzo
semanticscholar   +1 more source

Mapping VEXAS‐associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population

British Journal of Haematology, EarlyView.
VEXAS syndrome is a late‐onset inflammatory disorder with rheumatological and haematological features. Epidemiological studies of VEXAS syndrome so far have been limited. Analysis of various UK cohorts estimates the incidence of VEXAS to be 1.51/100 000, or 171 new cases in the population of men over the age of 50 who are being investigated for myeloid
Ana Martinez Rodriguez, Leon Chang, Dorota Rowczenio, Alexandra Smith, Ebun Omoyinmi, James A. Poulter, Andrew McGregor, Sebastian Francis, Roochi Trikha, Adam Al‐Hakim, Kar Lok Kong, David G. Kent, Helen Lachmann, Austin Kulasekararaj, Catherine Cargo, Sinisa Savic   +15 more
wiley   +1 more source

AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcome [PDF]

, 2008
Ashutosh Wechalekar, Helen J. Lachmann, Hugh J. B. Goodman, A.R. Bradwell, Philip N. Hawkins, Julian D. Gillmore   +5 more
openalex   +1 more source

The molecular landscape of AL amyloidosis. [PDF]

Br J Haematol
Zvida-Bloch T, Muchtar E, Dispenzieri A, Shpilberg O, Hershkovitz-Rokah O.   +4 more
europepmc   +1 more source

Primary (AL) Amyloidosis

Renal Failure, 1993
openaire   +3 more sources

Primary myelofibrosis with increased haemoglobin concentration at presentation

British Journal of Haematology, EarlyView.
Subjects with primary myelofibrosis and elevated haemoglobin levels at diagnosis tend to have longer survival rates (OS) and blast transformation‐free survival (BTFS) than those with normal or reduced haemoglobin levels. Summary One hundred of 963 consecutive registrants with primary myelofibrosis (PMF) in the Pavia‐CSM database had haemoglobin ...
Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Adriana Carolei, Margherita Massa, Annalisa De Silvestri, Robert Peter Gale, Vittorio Rosti   +8 more
wiley   +1 more source

91: Myeloma with AL Amyloidosis: 10 Years Experience with Stem Cell Transplant [PDF]

, 2008
L. Silva, D. Weber, M. Wang, Eric Han, Floralyn Mendoza, Marcos de Lima, Muzaffar H. Qazilbash, Richard E. Champlin, Sergio Giralt   +8 more
openalex   +1 more source

Molecular Expression Differences in Specific Blood Mononuclear Cell-Types Identify Patients With AL Amyloidosis. [PDF]

J Cell Mol Med
Kaplan D, Christian E, Valent J, Anwer F, Mazzoni S, Samaras C, Williams L, Nakashima M, Raza S, Hanna M, Lazarus HM, Khouri J.   +11 more
europepmc   +1 more source

Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis

, 2005
Julian D. Gillmore, Hugh J. B. Goodman, Helen J. Lachmann, Mark Offer, Ashutosh Wechalekar, Jayshree Joshi, Mark B. Pepys, Philip N. Hawkins   +7 more
openalex   +1 more source